Baeocystin
From Wikipedia, the free encyclopedia
Baeocystin
|
|
Systematic (IUPAC) name | |
3-[2-(Methylammonio)ethyl]-
1H-indol-4-yl hydrogen phosphate |
|
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C11H15N2O4P |
Mol. mass | 270.22 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Baeocystin is a mushroom alkaloid and analog of the psychedelic hallucinogenic drug psilocybin, a tryptamine derivative. It is found as a minor compound in most psychoactive mushrooms together with psilocybin, norbaeocystin, and psilocin. Little information exists with regard to human pharmacology, but a dosage of 10mg is reported to produce entheogenic effects.[specify]
First isolated from the mushroom Psilocybe baeocystis,[1] baeocystin is a demethylated derivative of psilocybin.
[edit] References
- ^ Leung, A.Y. and A.G. Paul. "Baeocystin and Norbaeocystin: New Analogs of Psilocybin from Psilocybe baeocystis." Journal of Pharmaceutical Sciences 57(10): 1667-1671 (1968).
- DB Repke, DT Leslie, G Guzman. "Baeocystin in Psilocybe, Conocybe and Panaeolus." Lloydia. 1977 Nov-Dec;40(6):566-78.
|